相似文献
1
Editorial for Special Issue 'Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition'.
Pharmaceutics. 2025 Jun 10;17(6):763. doi: 10.3390/pharmaceutics17060763.
2
Editorial for Special Issue 'Engineering and Characterisation of Novel Nanomedicine Formulations'.
Pharmaceutics. 2024 Apr 26;16(5):585. doi: 10.3390/pharmaceutics16050585.
3
Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1990. doi: 10.1002/wnan.1990.
4
Bioinspired and bioderived nanomedicine for inflammatory bowel disease.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug;16(4):e1986. doi: 10.1002/wnan.1986.
5
Advances in Nanomedicine for Cancer Theranostics.
Biomed Mater. 2025 Jun 18;20(4). doi: 10.1088/1748-605X/addf26.
6
Revolutionizing Diabetes Management Through Nanotechnology-Driven Smart Systems.
Pharmaceutics. 2025 Jun 13;17(6):777. doi: 10.3390/pharmaceutics17060777.
7
Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
Cardiovasc Hematol Disord Drug Targets. 2017;17(2):119-131. doi: 10.2174/1871529X17666170918142653.
8
Nanomedicine-Driven Approaches for Kartogenin Delivery: Advancing Chondrogenic Differentiation and Cartilage Regeneration in Tissue Engineering.
Int J Nanomedicine. 2025 Jun 13;20:7443-7468. doi: 10.2147/IJN.S525580. eCollection 2025.
9
Challenges of enzyme therapy: Why two players are better than one.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug;16(4):e1979. doi: 10.1002/wnan.1979.
10
Innovative Approaches in Cancer Treatment: Emphasizing the Role of Nanomaterials in Tyrosine Kinase Inhibition.
Pharmaceutics. 2025 Jun 16;17(6):783. doi: 10.3390/pharmaceutics17060783.
本文引用的文献
1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines.
Vaccines (Basel). 2023 Mar 14;11(3):658. doi: 10.3390/vaccines11030658.
3
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.
Biomater Sci. 2023 Jun 13;11(12):4238-4253. doi: 10.1039/d2bm01846b.
4
Lipid nanoparticles in the development of mRNA vaccines for COVID-19.
J Drug Deliv Sci Technol. 2022 Aug;74:103553. doi: 10.1016/j.jddst.2022.103553. Epub 2022 Jun 28.
5
The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome-A Systematic Review.
J Clin Med. 2022 Feb 17;11(4):1044. doi: 10.3390/jcm11041044.
6
Magnetically Driven Micro and Nanorobots.
Chem Rev. 2021 Apr 28;121(8):4999-5041. doi: 10.1021/acs.chemrev.0c01234. Epub 2021 Mar 31.
7
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
J Family Med Prim Care. 2019 Oct 31;8(10):3173-3178. doi: 10.4103/jfmpc.jfmpc_522_19. eCollection 2019 Oct.
8
Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes.
J Control Release. 2017 May 28;254:75-91. doi: 10.1016/j.jconrel.2017.03.392. Epub 2017 Mar 30.
9
Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.
Int J Nanomedicine. 2016 Apr 26;11:1687-700. doi: 10.2147/IJN.S103332. eCollection 2016.
10
Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.
J Drug Deliv. 2013;2013:340315. doi: 10.1155/2013/340315. Epub 2013 Jun 27.
Zotero 插件